160 related articles for article (PubMed ID: 8170041)
1. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease.
Reilly JM; Sicard GA; Lucore CL
J Vasc Surg; 1994 May; 19(5):865-72. PubMed ID: 8170041
[TBL] [Abstract][Full Text] [Related]
2. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
[TBL] [Abstract][Full Text] [Related]
3. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta.
McMillan WD; Patterson BK; Keen RR; Pearce WH
J Vasc Surg; 1995 Sep; 22(3):295-305. PubMed ID: 7674473
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.
Shireman PK; McCarthy WJ; Pearce WH; Patterson BK; Shively VP; Cipollone M; Tamarina N; Verrusio EN; Kwaan HC
J Vasc Surg; 1996 May; 23(5):810-7; discussion 817-8. PubMed ID: 8667502
[TBL] [Abstract][Full Text] [Related]
5. Abnormal levels of urokinase plasminogen activator protein and tissue plasminogen activator activity in human aortic aneurysms.
Falkenberg M; Holmdahl L; Tjärnström J; Risberg B
Eur J Surg; 2001 Jan; 167(1):10-4. PubMed ID: 11213813
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease.
Saito S; Zempo N; Yamashita A; Takenaka H; Fujioka K; Esato K
Vasc Endovascular Surg; 2002; 36(1):1-7. PubMed ID: 12704518
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activators in abdominal aortic aneurysmal disease.
Reilly JM
Ann N Y Acad Sci; 1996 Nov; 800():151-6. PubMed ID: 8958990
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture.
Louwrens HD; Kwaan HC; Pearce WH; Yao JS; Verrusio E
Eur J Vasc Endovasc Surg; 1995 Oct; 10(3):289-93. PubMed ID: 7552526
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.
Fontaine V; Jacob MP; Houard X; Rossignol P; Plissonnier D; Angles-Cano E; Michel JB
Am J Pathol; 2002 Nov; 161(5):1701-10. PubMed ID: 12414517
[TBL] [Abstract][Full Text] [Related]
10. Fibrin autography of plasminogen activator by electrophoretic transfer into fibrin agar gels.
Brunner G; Schirrmacher V
Anal Biochem; 1988 Feb; 168(2):411-6. PubMed ID: 3364738
[TBL] [Abstract][Full Text] [Related]
11. Cysteine protease activity in the wall of abdominal aortic aneurysms.
Abisi S; Burnand KG; Waltham M; Humphries J; Taylor PR; Smith A
J Vasc Surg; 2007 Dec; 46(6):1260-6. PubMed ID: 18155003
[TBL] [Abstract][Full Text] [Related]
12. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms.
Houard X; Rouzet F; Touat Z; Philippe M; Dominguez M; Fontaine V; Sarda-Mantel L; Meulemans A; Le Guludec D; Meilhac O; Michel JB
J Pathol; 2007 May; 212(1):20-8. PubMed ID: 17352452
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic system of cultured rabbit aortic endothelial cells.
al-Azhary DB; Wojta J; Binder BR
Thromb Res; 1994 Sep; 75(5):559-68. PubMed ID: 7992256
[TBL] [Abstract][Full Text] [Related]
14. Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.
Dong Q; Zhou MH; Subbarao V; Ts'ao CH
Br J Exp Pathol; 1988 Oct; 69(5):685-95. PubMed ID: 3143395
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease.
Dubick MA; Keen CL; DiSilvestro RA; Eskelson CD; Ireton J; Hunter GC
Proc Soc Exp Biol Med; 1999 Jan; 220(1):39-45. PubMed ID: 9893167
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells.
Keen RR; Nolan KD; Cipollone M; Scott E; Shively VP; Yao JS; Pearce WH
J Vasc Surg; 1994 Nov; 20(5):774-84; discussion 784-6. PubMed ID: 7966813
[TBL] [Abstract][Full Text] [Related]
18. Vascular smooth muscle cell apoptosis in aneurysmal, occlusive, and normal human aortas.
Rowe VL; Stevens SL; Reddick TT; Freeman MB; Donnell R; Carroll RC; Goldman MH
J Vasc Surg; 2000 Mar; 31(3):567-76. PubMed ID: 10709071
[TBL] [Abstract][Full Text] [Related]
19. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
20. TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas.
Defawe OD; Colige A; Lambert CA; Munaut C; Delvenne P; Lapière CM; Limet R; Nusgens BV; Sakalihasan N
Cardiovasc Res; 2003 Oct; 60(1):205-13. PubMed ID: 14522424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
